SMARCA4 and gastric cancer: Inactivation of SMARCA4 rarely occurs in classic glandular gastric cancer as a driver molecular event and is more likely to occur in gastric cancer with solid and poorly differentiated and undifferentiated morphology [6, 13, 16, 26], and loss of SMARCA4 is associated with adverse clinical characteristics [11, 12].